scispace - formally typeset
W

Wen-Lin Xu

Researcher at Jiangsu University

Publications -  21
Citations -  439

Wen-Lin Xu is an academic researcher from Jiangsu University. The author has contributed to research in topics: Daunorubicin & MTT assay. The author has an hindex of 11, co-authored 21 publications receiving 418 citations.

Papers
More filters
Journal ArticleDOI

Biocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignancies

TL;DR: Self-assembled Fe3O4-MNPs/DNR appear to be highly biocompatible and safe nanoparticles, and may be suitable for further application in the treatment of hematologic malignancies.
Journal ArticleDOI

Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia

TL;DR: TET-DEC was relatively well tolerated in patients with poor risk AML, and had encouraging antileukemic effects, and there was no difference in DNR uptake between responding and non-responding patients.
Journal ArticleDOI

Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells.

TL;DR: It is proposed that Fe3O4-MNPs loaded with ADM and Tet probably have synergetic effect on reversal in multidrug resistance and can enhance the effective accumulation of the drugs in K562/A02.
Journal ArticleDOI

Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells.

TL;DR: In vitro data strongly suggests a potential clinical application of MNP(Fe3O4) and BrTet combination on CML, and confirmed that the distinct synergism effect of that composite on reverse multidrug resistance may owe to the regulation of various proliferative and antiapoptotic gene products.
Journal ArticleDOI

Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo

TL;DR: DNR-loaded MNPs-Fe3O4 can overcome MDR in vivo, and the transcriptions and expressions of Bax and caspase-3 in group D were increased significantly when compared with groups A, B, and C.